GlassScriptPhysician profile
Isra E Ahmed
NPI 1154817666
$59,914.37
in general payments reported to CMS, 2019-2025
8 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.38 · 2020: $277 · 2021: $1,410 · 2022: $56.49 · 2023: $753 · 2024: $30K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Travel and Lodging: $5,145 · Food and Beverage: $1,571 · Education: $50.00 · Entertainment: $37.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,355.00 |
| Travel and Lodging | $5,144.74 |
| Food and Beverage | $1,571.28 |
| Education | $50.00 |
| Entertainment | $37.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $57,229.02 | 2023-2025 | |
| Straumann USA LLC | $1,313.35 | 2019-2024 | |
| Nobel Biocare USA | $781.83 | 2020-2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $334.92 | 2020-2021 | |
| Keystone Dental INC. | $153.11 | 2023-2024 | |
| Envista Holdings Corporation | $74.17 | 2024-2025 | Nx3 |
| Dentsply Sirona INC | $14.16 | 2025 | Cerec |
| Philips North America LLC | $13.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isra Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.